Translate Bio, Inc. insider trading activity

Understanding Insider Activity at Translate Bio, Inc.

Welcome to our dedicated page for Translate Bio, Inc. (Nasdaq: TBIO) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by Translate Bio, Inc.'s key insiders, providing a unique window into the company's internal sentiments.

How to Use This Data:

Below, you can view insider transactions that were reported to the SEC within the last 365 days.

While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.

Scroll down to view the most recent insider transactions for Translate Bio, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.

Track insider trades for TBIO
TickerTime & DateFilingLink
TBIO12:11:07 AM 5/9/2023
Nelson Todd Robert(President & CEO) sold 2575 shares of Telesis Bio Inc. (TBIO) for ~$7287
Filing
TBIO12:09:45 AM 5/9/2023
Gibson Daniel Glenn(Chief Technology Officer) sold 1190 shares of Telesis Bio Inc. (TBIO) for ~$3367
Filing
TBIO12:06:35 AM 5/9/2023
Cutler Rob(Chief Legal Officer) sold 1174 shares of Telesis Bio Inc. (TBIO) for ~$3322
Filing